A new study claims that those using e-cigarettes to quit smoking found them to be less helpful than more traditional smoking cessations aids such as patches and gum.
The study, published Monday in the journal BMJ, analyzed the latest 2017 to 2019 data from the Population Assessment of Tobacco and Health (PATH) Study, which follows tobacco use among Americans over time.
“This is the first time we found e-cigarettes to be less popular than FDA-approved pharmaceutical aids, such as medications or the use of patches, gum, or lozenges,” said John Pierce, the director for population sciences at the Moores Cancer Center at the University of California, San Diego, according to CNN.
A three-month randomized trial in the United Kingdom, published in 2019, found e-cigarettes, along with behavioral interventions, did help smokers quit tobacco cigarettes. In guidance published in late 2021, the UK National Institute for Health and Care Excellence decided to recommend that smokers use e-cigarettes to help them quit.
Another recent study, published in JAMA Network Open, found adult smokers with no plans to quit are more likely to stop smoking if they switch to daily vaping, according to new research led by Roswell Park Comprehensive Cancer Center.
The Roswell Park study also used data collected from 2014 to 2019 as part of the PATH study.
One new brand at the show, Hook’d – with its tagline “one puff and you’re Hook’d” – seemed to take taunting the U.S. Food and Drug Administration to another level according to Kim, a show attendee who asked not to use her last name. “Why would you put a brand out there like that,” she said. “It’s just disappointing.” A person working the Hook’d booth, when asked why the Hook’d name, told Vapor Voice the name was “just catchy.”